MedTrace Logo

Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.

NCT04553796 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2020-12-23

No results posted yet for this study

Summary

assessment of NAFLD among diabetic, pre-diabetic and non diabetic participants Using Non Invasive Methods.And correlation between lab and radiological methods .

Conditions

  • Non Alcoholic Fatty Liver

Interventions

DEVICE

fibroscan

Fibroscan is a non-invasive test that helps assess the health of your liver. Specifically, it uses ultrasound technology to determine the degree of fibrosis or scarring that may be present in your liver from various liver diseases or conditions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • lobna a ahmed, professor · Assiut University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-01-01
Completion
2022-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04553796 on ClinicalTrials.gov